SUZANNE FUQUA to Gene Expression Profiling
This is a "connection" page, showing publications SUZANNE FUQUA has written about Gene Expression Profiling.
Connection Strength
0.865
-
ESR1 mutations in breast cancer. Cancer. 2019 11 01; 125(21):3714-3728.
Score: 0.394
-
The promise of microarrays in the management and treatment of breast cancer. Breast Cancer Res. 2005; 7(3):100-4.
Score: 0.146
-
Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERa-positive breast cancer. Breast Cancer Res Treat. 2015 Nov; 154(2):225-37.
Score: 0.076
-
Pharmacogenetics of breast cancer: toward the individualization of therapy. Cancer Invest. 2009 Aug; 27(7):699-703.
Score: 0.049
-
Inhibition of mammary tumorigenesis by estrogen and progesterone in genetically engineered mice. Ernst Schering Found Symp Proc. 2007; (1):109-26.
Score: 0.041
-
Evidence for diversity in transcriptional profiles of single hematopoietic stem cells. PLoS Genet. 2006 Sep 29; 2(9):e159.
Score: 0.040
-
Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance. Cancer Res. 2006 Jun 01; 66(11):5950-9.
Score: 0.040
-
Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer. Clin Cancer Res. 2015 Apr 01; 21(7):1688-98.
Score: 0.018
-
Novel insights into breast cancer genetic variance through RNA sequencing. Sci Rep. 2013; 3:2256.
Score: 0.016
-
Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression. Breast Cancer Res. 2012 Jun 14; 14(3):R95.
Score: 0.015
-
Transcriptomic landscape of breast cancers through mRNA sequencing. Sci Rep. 2012; 2:264.
Score: 0.015
-
Leptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cells. Cancer Res. 2012 Mar 15; 72(6):1416-27.
Score: 0.015